Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/management-of-thyroid-cancer/pathak/descriptif_3271773
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3271773

Management of Thyroid Cancer, Softcover reprint of the original 1st ed. 2015 Special Considerations Head and Neck Cancer Clinics Series

Langue : Anglais

Coordonnateurs : Pathak K. Alok, Nason Richard W., Pasieka Janice L.

Couverture de l’ouvrage Management of Thyroid Cancer
Thyroid cancer is the most common malignant endocrine tumor and is the seventh most common cancer seen in throughout out the world. The incidence of thyroid cancer has been increasing more rapidly than any other cancer in many of the cancer registries from different parts of the world.
Although the majority of thyroid cancers have an indolent biological behaviour, different histological types have a diverse clinical behaviour. Well-differentiated thyroid cancers have an excellent survival, whereas poorly differentiated and anaplastic thyroid cancers have a very poor outcome. This volume of Head and Neck Cancer Clinics addresses advances, controversies and state-of-the-art treatment recommendations of various types of thyroid cancers.  
​ Molecular risk stratification of well-differentiated thyroid cancer.- The significance of cervical lymph nodes in well-differentiated thyroid cancer.- Management of the central compartment in well-differentiated thyroid carcinoma.- Management of the lateral neck in   well-differentiated thyroid cancer.- The management of recurrent/persistent well-differentiated thyroid cancer in the central compartment.- Management of distant metastases in differentiated thyroid cancer.- Risk-adjusted strategies in post-treatment surveillance of well-differentiated thyroid carcinoma.- Medullary thyroid cancer.- Anaplastic thyroid cancer: Current concepts.- External beam radiotherapy for thyroid cancer.- Targeted therapies in thyroid cancer.

 K. Alok Pathak
Professor of Surgery
University of Manitoba
Head and Neck Surgical Oncology
Cancer Care Manitoba, Canada

Richard W. Nason
Professor
Head and Neck Surgical Oncology
Cancer Care Manitoba
Winnipeg, Canada 

Janice L. Pasieka
Clinical Professor of Surgery and Oncology
Section of General Surgery and Surgical Oncology
University of Calgary, Canada

Encompasses the molecular risk stratification Management of regional and distant metastatic thyroid cancer Salvage of central compartment recurrence, role of external beam radiation therapy and post-treatment surveillance of thyroid cancer Management of medullary and anaplastic thyroid cancer and the evolving role of targeted therapy in thyroid cancer have been discussed in separate chapters Each chapter is followed by an editorial commentary

Date de parution :

Ouvrage de 145 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

52,74 €

Ajouter au panier

Date de parution :

Ouvrage de 145 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

52,74 €

Ajouter au panier

Ces ouvrages sont susceptibles de vous intéresser


Thyroid Cancer
232,09 €